Enrofloxacin
SIAL/17849 - ≥99.0%
Synonym: Baytril
CAS Number: 93106-60-6
Empirical Formula (Hill Notation): C19H22FN3O3
Molecular Weight: 359.39
MDL Number: MFCD00792463
Linear Formula: C19H22FN3O3
Product Type: Chemical
antibiotic activity spectrum | Gram-negative bacteria |
Gram-positive bacteria | |
assay | ≥99.0% |
99.0-101.0% (dried substance) | |
form | powder or crystals |
InChI | 1S/C19H22FN3O3/c1-2-21-5- |
InChI key | SPFYMRJSYKOXGV-UHFFFAOYSA |
mode of action | DNA synthesis | interferes |
enzyme | inhibits | |
Quality Level | 200 |
SMILES string | CCN1CCN(CC1)c2cc3N(C=C(C( |
Application: | Enrofloxacin has been used: • to investigate the pathological mechanisms resulting from the toxicity of fluoroquinolones in mammalian cells • to prepare a standard solution with 50% acetonitrile in a study to analyze illegal fish drugs used in aquaculture by employing surface-enhanced Raman spectroscopy (SERS) • as an analyte in a chemiluminescence reagent system |
General description: | Chemical structure: fluoroquinolone |
General description: | Enrofloxacin is a veterinary fluoroquinolone (FQ) antibiotic with broad-spectrum antimicrobial activity. FQ drugs chelate to iron with high affinity. This chelation leads to inhibition of Fe(II)-dependent dioxygenases involved in the regulation of epigenetic control, collagen maturation, and HIF (hypoxia-inducible factor) degradation. The side effects associated with FQ drugs are renal toxicity and tendinopathy. Enrofloxacin is used in aquaculture and its use may cause an increase in the growth of antibiotic resistant microbes in an aquatic environment. The drug may have negative effects on public health and environment. |
Symbol | GHS07,GHS08 |
Signal word | Danger |
Hazard statements | H302 - H317 - H334 |
Precautionary statements | P261 - P264 - P270 - P280 - P301 + P312 - P302 + P352 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Purity | ≥99.0%; 99.0-101.0% (dried substance) |
UNSPSC | 41116105 |